The TRUTH About Big Pharma’s Patent Abuse

Big Pharma has a long history of price-gouging American patients by gaming the U.S. patent system and blocking competition from more affordable alternatives, like generics and biosimilars. Why? Because these anti-competitive tactics allow Big Pharma to maintain monopolies over their biggest money-makers.

PhRMA recently launched a new ad campaign seeking to deflect scrutiny from Big Pharma’s egregious abuse of the patent system. This latest round of misleading advertising is meant to defend the anti-competitive status quo and keep drug prices high.

The truth is, Big Pharma often invests more boldly in profits, advertising and developing new and more effective strategies to exploit loopholes to extend monopoly pricing on blockbuster products than in true innovation.

Here we set the record straight with a second opinion on Big Pharma’s latest misleading ad campaign… take a look: